Christopher Cardozo

Prof. Christopher Cardozo

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2019 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
DDDibash Das
Dibash Das
ZGZachary A. Graham
Zachary A. Graham
CCChristopher Cardozo
Christopher Cardozo

4 July 2015 in Journal of Muscle Research and Cell Motility
Verified
Journal Article
Closed access
PDF file
ZGZachary Graham
Zachary Graham
PGPhilip Gallagher
Philip Gallagher
CCChristopher Cardozo
Christopher Cardozo

1 February 2003 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
CCChristopher Cardozo
Christopher Cardozo
CMCharlene Michaud
Charlene Michaud
MOMichael C Ost
Michael C Ost
AFAlbert E Fliss
Albert E Fliss
EYEmy Yang
Emy Yang
ACAvrom J Caplan
Avrom J Caplan

16 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RGRita De Gasperi
Rita De Gasperi
SHSayyed Hamidi
Sayyed Hamidi
LHLauren M. Harlow
Lauren M. Harlow
HKHanna Ksiezak-Reding
Hanna Ksiezak-Reding
WBWilliam A. Bauman
William A. Bauman
CCChristopher Cardozo
Christopher Cardozo
Exosomes are vesicles released by many eukaryotic cells; their cargo includes proteins, mRNA and microRNA (miR) that can be transferred to recipient cells and regulate cellular processes in an autocrine or paracrine manner. While cells of the myoblast lineage secrete exosomes, it is not known whether skeletal muscle fibers (myofibers) release exosomes. In this study, we found that cultured myofibers release nanovesicles that have bilamellar membranes and an average size of 60–130 nm, contain typical exosomal proteins and miRNAs and are taken up by C2C12 cells. miR-133a was found to be the most abundant myomiR in these vesicles while miR-720 was most enriched in exosomes compared to parent myofibers. Treatment of NIH 3T3 cells with myofiber-derived exosomes downregulated the miR-133a targets proteins Smarcd1 and Runx2, confirming that these exosomes have biologically relevant effects on recipient cells. Denervation resulted in a marked increase in miR-206 and reduced expression of miRs 1, 133a, and 133b in myofiber-derived exosomes. These findings demonstrate that skeletal muscle fibers release exosomes which can exert biologically significant effects on recipient cells, and that pathological muscle conditions such as denervation induce alterations in exosomal miR profile which could influence responses to disease states through autocrine or paracrine mechanisms.

23 December 2009 in Endocrinology
Verified
Journal Article
Open access
PDF file
YWYong Wu
Yong Wu
WZWeidong Zhao
Weidong Zhao
JZJingbo Zhao
Jingbo Zhao
YZYuanfei Zhang
Yuanfei Zhang
WQWeiping Qin
Weiping Qin
CCChristopher Cardozo
Christopher Cardozo
Glucocorticoids are a well-recognized and common cause of muscle atrophy that can be prevented by testosterone. However, the molecular mechanisms underlying such protection have not been described. Thus, the global effects of testosterone on dexamethasone-induced changes in gene expression were evaluated in rat gastrocnemius muscle using DNA microarrays. Gene expression was analyzed after 7-d administration of dexamethasone, dexamethasone plus testosterone, or vehicle. Dexamethasone changed expression of 876 probe sets by at least 2-fold. Among these, 474 probe sets were changed by at least 2-fold in the opposite direction in the dexamethasone plus testosterone group (genes in opposition). Major biological themes represented by genes in opposition included IGF-I signaling, myogenesis and muscle development, and cell cycle progression. Testosterone completely prevented the 22-fold increase in expression of the mammalian target of rapamycin (mTOR) inhibitor regulated in development and DNA damage responses 1 (REDD1), and attenuated dexamethasone induced increased expression of eIF4E binding protein 1, Forkhead box O1, and the p85 regulatory subunit of the IGF-I receptor but prevented decreased expression of IRS-1. Testosterone attenuated increases in REDD1 protein in skeletal muscle and L6 myoblasts and prevented dephosphorylation of p70S6 kinase at the mTOR-dependent site Thr389 in L6 myoblast cells. Effects of testosterone on REDD1 mRNA levels occurred within 1 h, required the androgen receptor, were blocked by bicalutamide, and were due to inhibition of transcriptional activation of REDD1 by dexamethasone. These data suggest that testosterone blocks dexamethasone-induced changes in expression of REDD1 and other genes that collectively would otherwise down-regulate mTOR activity and hence also down-regulate protein synthesis.

7 September 2010 in Current Osteoporosis Reports
Verified
Journal Article
Closed access
PDF file
WQWeiping Qin
Weiping Qin
WBWilliam A. Bauman
William A. Bauman
CCChristopher Cardozo
Christopher Cardozo